Arnon P. Kater — Amsterdam UMC research portal

4.9 (96) · € 27.50 · Auf Lager

Arnon KATER, Clinical Hematologist and senior investigator, MD, PhD, Academisch Medisch Centrum Universiteit van Amsterdam, Amsterdam, AMC, Department of Hematology

Arnon KATER, Clinical Hematologist and senior investigator, MD, PhD, Academisch Medisch Centrum Universiteit van Amsterdam, Amsterdam, AMC, Department of Hematology

ERC Proof of Concept Grant for Arnon Kater

JAK–STAT signalling shapes the NF‐κB response in CLL towards venetoclax sensitivity or resistance via Bcl‐XL - Haselager - 2023 - Molecular Oncology - Wiley Online Library

Chronic lymphocytic leukemia presence impairs antigen-specific CD8+ T-cell responses through epigenetic reprogramming towards short-lived effectors

Arnon KATER, Doctor of Medicine, Academisch Medisch Centrum Universiteit van Amsterdam, Amsterdam, AMC

SARS-CoV-2 hyperimmune globulin for severely immunocompromised patients with COVID-19: a randomised, controlled, double-blind, phase 3 trial

JAK–STAT signalling shapes the NF‐κB response in CLL towards venetoclax sensitivity or resistance via Bcl‐XL - Haselager - 2023 - Molecular Oncology - Wiley Online Library